LeMaitre Vascular Company Insiders
| LMAT Stock | USD 87.66 1.06 1.22% |
LeMaitre Vascular's insiders are aggressively selling. The analysis of insiders' sentiment of trading LeMaitre Vascular stock suggests that vertually all insiders are panicking at this time. LeMaitre Vascular employs about 651 people. The company is managed by 16 executives with a total tenure of roughly 139 years, averaging almost 8.0 years of service per executive, having 40.69 employees per reported executive.
| George LeMaitre Chairman Chairman and CEO |
| David Roberts President President Director |
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-08-11 | John A Roush | Disposed 6561 @ 92.55 | View | ||
| 2025-08-08 | John A Roush | Disposed 939 @ 93.49 | View | ||
| 2025-08-06 | George W Lemaitre | Disposed 100000 @ 93.51 | View | ||
| 2025-05-20 | George W Lemaitre | Disposed 4399 @ 85.1 | View | ||
| 2025-05-19 | George W Lemaitre | Disposed 76868 @ 85.79 | View | ||
| 2025-05-16 | George W Lemaitre | Disposed 18733 @ 84.77 | View | ||
| 2025-03-12 | Trent G Kamke | Disposed 2009 @ 82.12 | View |
Monitoring LeMaitre Vascular's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. LeMaitre Vascular's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with LeMaitre Vascular's future performance. Based on our forecasts, it is anticipated that LeMaitre will maintain a workforce of slightly above 650 employees by March 2026.LeMaitre Vascular Management Team Effectiveness
The company has return on total asset (ROA) of 0.0794 % which means that it generated a profit of $0.0794 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1502 %, meaning that it created $0.1502 on every $100 dollars invested by stockholders. LeMaitre Vascular's management efficiency ratios could be used to measure how well LeMaitre Vascular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2026. Return On Capital Employed is likely to drop to 0.06 in 2026. At this time, LeMaitre Vascular's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 666.3 M in 2026, whereas Non Current Liabilities Other is likely to drop slightly above 283 K in 2026.Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.6 M in 2026. LeMaitre Vascular maintains a total of 22.69 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost one million sixty-six thousand two hundred fourty-two invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.
Shares in Circulation | First Issued 2004-03-31 | Previous Quarter 22.9 M | Current Value 24.4 M | Avarage Shares Outstanding 17.3 M | Quarterly Volatility 4.5 M |
LeMaitre Vascular Workforce Comparison
LeMaitre Vascular is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 84,738. LeMaitre Vascular maintains roughly 651 in number of employees contributing less than 1% to equities under Health Care industry.
LeMaitre Vascular Profit Margins
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.76 | 0.79 |
|
|
LeMaitre Vascular Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, LeMaitre Vascular insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 1.0 | 4 | 4 | 5,023 | 5,023 |
| 2025-12-01 | 1.6795 | 131 | 78 | 146,576 | 58,308 |
| 2025-09-01 | 3.1 | 62 | 20 | 42,225 | 206,306 |
| 2025-06-01 | 5.0833 | 61 | 12 | 38,501 | 142,119 |
| 2025-03-01 | 3.6818 | 81 | 22 | 13,990 | 18,179 |
| 2024-12-01 | 1.4026 | 108 | 77 | 90,515 | 44,464 |
| 2024-09-01 | 5.75 | 46 | 8 | 3,333 | 103,868 |
| 2024-06-01 | 3.3846 | 44 | 13 | 5,599 | 225,425 |
| 2024-03-01 | 1.7073 | 70 | 41 | 68,370 | 209,590 |
| 2023-12-01 | 1.3934 | 85 | 61 | 120,187 | 115,556 |
| 2023-09-01 | 29.0 | 29 | 1 | 93.14 | 625.00 |
| 2023-06-01 | 1.3571 | 38 | 28 | 66,703 | 305,140 |
| 2023-03-01 | 3.1818 | 35 | 11 | 28,091 | 54,106 |
| 2022-12-01 | 1.4255 | 67 | 47 | 145,360 | 69,576 |
| 2022-09-01 | 1.7692 | 23 | 13 | 32,221 | 65,919 |
| 2022-03-01 | 4.2 | 21 | 5 | 12,710 | 22,187 |
| 2021-12-01 | 1.2 | 54 | 45 | 155,043 | 84,946 |
| 2021-09-01 | 1.75 | 21 | 12 | 408.00 | 3,672 |
| 2021-06-01 | 1.037 | 28 | 27 | 49,218 | 312,047 |
| 2021-03-01 | 1.5 | 24 | 16 | 24,777 | 243,082 |
| 2020-12-01 | 0.7684 | 73 | 95 | 314,488 | 539,338 |
| 2020-09-01 | 1.6 | 24 | 15 | 45,972 | 64,025 |
| 2020-06-01 | 19.0 | 19 | 1 | 40,275 | 20,000 |
| 2020-03-01 | 2.3 | 23 | 10 | 18,233 | 80,875 |
| 2019-12-01 | 0.6724 | 39 | 58 | 237,298 | 561,365 |
| 2019-09-01 | 0.8387 | 26 | 31 | 134,643 | 320,173 |
| 2019-06-01 | 13.0 | 26 | 2 | 77,249 | 77,032 |
| 2019-03-01 | 0.75 | 3 | 4 | 47,494 | 64,098 |
| 2018-12-01 | 2.2727 | 25 | 11 | 181,780 | 52,203 |
| 2018-09-01 | 0.9091 | 20 | 22 | 124,188 | 201,067 |
| 2018-06-01 | 1.3529 | 23 | 17 | 54,758 | 133,748 |
| 2018-03-01 | 0.1111 | 1 | 9 | 16,328 | 151,918 |
| 2017-12-01 | 8.0 | 16 | 2 | 141,561 | 11,893 |
| 2017-09-01 | 0.5455 | 30 | 55 | 220,721 | 604,749 |
| 2017-06-01 | 0.913 | 21 | 23 | 185,960 | 460,046 |
| 2017-03-01 | 0.5 | 3 | 6 | 74,666 | 89,531 |
| 2016-12-01 | 2.0 | 8 | 4 | 3,100 | 35,995 |
| 2016-09-01 | 0.6735 | 33 | 49 | 405,968 | 437,864 |
| 2016-06-01 | 0.2105 | 8 | 38 | 79,875 | 310,179 |
| 2016-03-01 | 1.0 | 11 | 11 | 16,810 | 53,628 |
| 2015-12-01 | 0.3922 | 20 | 51 | 226,737 | 630,259 |
| 2015-09-01 | 0.5352 | 38 | 71 | 623,369 | 797,732 |
| 2015-06-01 | 0.4872 | 19 | 39 | 101,235 | 286,805 |
| 2015-03-01 | 0.2424 | 8 | 33 | 135,807 | 259,579 |
| 2014-09-01 | 1.2308 | 16 | 13 | 402,899 | 89,693 |
| 2014-06-01 | 0.3333 | 2 | 6 | 52,061 | 40,032 |
| 2014-03-01 | 0.1667 | 5 | 30 | 31,000 | 94,495 |
| 2013-12-01 | 0.0769 | 2 | 26 | 168,613 | 258,150 |
| 2013-09-01 | 0.5429 | 19 | 35 | 335,573 | 177,860 |
| 2013-06-01 | 0.2353 | 4 | 17 | 3,497 | 53,433 |
| 2013-03-01 | 0.3889 | 7 | 18 | 42,263 | 77,367 |
| 2012-12-01 | 0.1176 | 2 | 17 | 104,192 | 121,606 |
| 2012-09-01 | 0.3514 | 13 | 37 | 283,230 | 75,190 |
| 2012-06-01 | 0.5 | 4 | 8 | 14,000 | 10,718 |
| 2011-12-01 | 1.3333 | 4 | 3 | 5,500 | 1,619 |
| 2011-09-01 | 0.6818 | 15 | 22 | 225,389 | 23,720 |
| 2011-06-01 | 0.1765 | 3 | 17 | 41,500 | 168,916 |
| 2011-03-01 | 0.1786 | 5 | 28 | 41,891 | 106,978 |
| 2010-12-01 | 0.7368 | 14 | 19 | 31,637 | 74,717 |
| 2010-09-01 | 0.2308 | 18 | 78 | 225,305 | 185,762 |
| 2010-06-01 | 0.2821 | 11 | 39 | 19,000 | 132,595 |
| 2010-03-01 | 0.1739 | 4 | 23 | 7,552 | 20,121 |
| 2009-12-01 | 0.48 | 24 | 50 | 51,604 | 62,796 |
| 2009-09-01 | 1.1538 | 15 | 13 | 206,874 | 6,513 |
| 2009-06-01 | 0.5 | 2 | 4 | 1,600 | 2,860 |
| 2008-12-01 | 0.4 | 2 | 5 | 2,000 | 3,854 |
| 2008-09-01 | 1.25 | 10 | 8 | 126,276 | 12,631 |
| 2008-06-01 | 0.5 | 8 | 16 | 150,389 | 52,938 |
| 2008-03-01 | 0.0909 | 1 | 11 | 200.00 | 59,457 |
| 2007-06-01 | 5.0 | 5 | 1 | 18,000 | 3,500 |
| 2007-03-01 | 2.0 | 2 | 1 | 45,330 | 44,580 |
| 2006-12-01 | 3.1111 | 28 | 9 | 2,703,525 | 226,193 |
LeMaitre Vascular Notable Stakeholders
A LeMaitre Vascular stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as LeMaitre Vascular often face trade-offs trying to please all of them. LeMaitre Vascular's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting LeMaitre Vascular's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MD FACS | Founder Board | Profile | |
| George LeMaitre | Chairman and CEO | Profile | |
| David Roberts | President Director | Profile | |
| Kimberly Cieslak | Vice President - Marketing | Profile | |
| Ryan Connelly | Vice President - Research & Development | Profile | |
| Laurie Churchill | Senior Vice President General Counsel | Profile | |
| Stephane Maier | Vice President EMEA Operations | Profile | |
| Andrew Hodgkinson | Senior Vice President - Clinical, Regulatory and Quality Affairs | Profile | |
| Joseph Pellegrino | CFO, Principal Accounting Officer and Secretary | Profile | |
| Trent Kamke | Sr. VP of Operations | Profile | |
| Daniel Mumford | Director Resources | Profile | |
| Jonathan Ngau | Senior Technology | Profile | |
| Jacob Petersen | Senior International | Profile | |
| Dorian CPA | Chief Officer | Profile | |
| Maik Helmers | Senior Europe | Profile | |
| David Hissong | General Counsel | Profile |
About LeMaitre Vascular Management Performance
The success or failure of an entity such as LeMaitre Vascular often depends on how effective the management is. LeMaitre Vascular management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of LeMaitre management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the LeMaitre management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.06 | |
| Return On Capital Employed | 0.09 | 0.06 | |
| Return On Assets | 0.07 | 0.04 | |
| Return On Equity | 0.13 | 0.12 |
Please note, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Check LeMaitre Vascular's Beneish M Score to see the likelihood of LeMaitre Vascular's management manipulating its earnings.
LeMaitre Vascular Workforce Analysis
Traditionally, organizations such as LeMaitre Vascular use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare LeMaitre Vascular within its industry.LeMaitre Vascular Manpower Efficiency
Return on LeMaitre Vascular Manpower
| Revenue Per Employee | 337.7K | |
| Revenue Per Executive | 13.7M | |
| Net Income Per Employee | 67.6K | |
| Net Income Per Executive | 2.8M | |
| Working Capital Per Employee | 570.8K | |
| Working Capital Per Executive | 23.2M |
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.